Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 15, 2024. (Total: 231458Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Breast Neoplasms and MICA[original query]
The HLA class III subregion is responsible for an increased breast cancer risk.
Human molecular genetics 2003 Sep 12 (18): 2311-9.
de Jong Mirjam M, Nolte Ilja M, de Vries Elisabeth G E, Schaapveld Michael, Kleibeuker Jan H, Oosterom Elvira, Oosterwijk Jan C, van der Hout Annemarie H, van der Steege Gerrit, Bruinenberg Marcel, Boezen H Marike, Te Meerman Gerard J, van der Graaf Winette T
Correlation of major histocompatibility complex class I related A (MICA) polymorphism with the risk of developing breast cancer.
Medical oncology (Northwood, London, England) 2012 Mar 29 (1): 5-9.
Vallian Sadeq, Rad Morteza Javadi, Tavallaei Mahmood, Tavassoli Manooche
MMP9 Promoter Polymorphism (-1562 C/T) Does not Affect the Serum Levels of Soluble MICB and MICA in Breast Cancer.
Iranian journal of immunology : IJI 2016 Mar 13 (1): 45-53.
Bargostavan Mohammad Hasan, Eslami Gilda, Esfandiari Nasrin, Shams Shahemabadi A
MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk.
Immunological investigations 2017 Aug 46 (6): 603-614.
Ouni Nesrine, Ben Chaaben Arij, Kablouti Ghalia, Lajnef Mohamed, Ayari Fayza, Abaza Hajer, Damak Tarek, Harzallah Latifa, Benammar-Elgaaeid Amel, Guemira Fethi, Tamouza Ry
Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
Oncology research 2017 Mar .
Todorova Valentina K, Makhoul Issam, Dhakal Ishwori, Wei Jeanne, Stone Annjanette, Carter Weleetka, Owen Aaron, Klimberg V Suzan
MICA-129 Met/Val polymorphism could be a genetic biomarker for Familial Breast Cancer in the Tunisian population.
International journal of immunogenetics 2020 Feb .
Ouni Nesrine, Ben Chaaben Arij, Ayari Fayza, Douik Hayet, Guizani Imen, Benammar-Elgaaied Amel, Guemira Fethi, Tamouza Ry
Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load: results from the Drug Rediscovery Protocol.
Clinical cancer research : an official journal of the American Association for Cancer Research 2024 4 .
Birgit S Geurts, Laurien J Zeverijn, Lindsay V M Leek, Jade M van Berge Henegouwen, Louisa R Hoes, Hanneke van der Wijngaart, Vincent van der Noort, Joris van de Haar, Annemiek van Ommen-Nijhof, Marleen Kok, Paul Roepman, Anne M L Jansen, Wendy W J de Leng, Maja J A de Jonge, Ann Hoeben, Carla M L van Herpen, Hans M Westgeest, Lodewyk F A Wessels, Henk M W Verheul, Hans Gelderblom, Emile E Voe
TOP